The British Society for Haematology has just released a Guideline for the investigation and management of thrombocytosis (high platelets) without JAK2, CALR or MPL mutations. Some of these cases are diagnosed as triple-negative Essential Thrombocythemia (ET).
The full text of the Guideline, titled ‘Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline’ is freely accessible HERE.
